November 22, 2018
Oasmia’s Apalea approved in Europe for ovarian cancer
After the Oasmia Pharmaceutical’s pivotal study OAS 07OVA conducted on ovarian cancer patients with disease relapse, showed that the risks…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Apalea